Tianjin Ringpu Bio-TechnologyLtd 配当金
配当金 基準チェック /56
Tianjin Ringpu Bio-TechnologyLtd is a dividend paying company with a current yield of 2.15% that is well covered by earnings.
主要情報
2.2%
配当利回り
0.7%
バイバック利回り
総株主利回り | 2.9% |
将来の配当利回り | 3.3% |
配当成長 | 10.5% |
次回配当支払日 | n/a |
配当落ち日 | n/a |
一株当たり配当金 | CN¥0.400 |
配当性向 | 43% |
最近の配当金アップデート
Recent updates
These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well
Oct 30The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More
Oct 08Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 26Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet
Aug 23Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly
Jun 26Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)
Apr 05Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity
Mar 28決済の安定と成長
配当データの取得
安定した配当: 300119's dividends per share have been stable in the past 10 years.
増加する配当: 300119's dividend payments have increased over the past 10 years.
配当利回り対市場
Tianjin Ringpu Bio-TechnologyLtd 配当利回り対市場 |
---|
セグメント | 配当利回り |
---|---|
会社 (300119) | 2.2% |
市場下位25% (CN) | 0.6% |
市場トップ25% (CN) | 2.2% |
業界平均 (Pharmaceuticals) | 1.7% |
アナリスト予想 (300119) (最長3年) | 3.3% |
注目すべき配当: 300119's dividend (2.15%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
高配当: 300119's dividend (2.15%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
株主への利益配当
収益カバレッジ: With its reasonably low payout ratio (43.5%), 300119's dividend payments are well covered by earnings.
株主配当金
キャッシュフローカバレッジ: With its reasonable cash payout ratio (56.5%), 300119's dividend payments are covered by cash flows.